How A Doctor Cured His Own Terminal Disease | Dr. David Fajgenbaum
Many FDA-approved medications can treat diseases other than their original indication, offering hope for patients with rare and terminal conditions
Dr. David Fajgenbaum
1 episode on Huberman Lab
Dr. David Fajgenbaum is a professor of translational medicine and human genetics at the University of Pennsylvania and an expert in rare diseases and drug repurposing. He survived a terminal diagnosis of Castleman's disease by discovering an unconventional treatment using medications approved for other conditions, and now leads research into how existing drugs can treat previously untreatable diseases.